14731-14-7 Usage
General Description
5-(Bromoacetyl)-3-phenylisoxazole is a chemical compound with the molecular formula C10H8BrNO2. It is a highly reactive organic compound that contains a bromoacetyl group and a phenylisoxazole ring. This chemical is commonly used in the synthesis of pharmaceuticals and agrochemicals due to its ability to modify and enhance the properties of certain molecules. It can also act as an intermediate in the production of various organic compounds. Additionally, 5-(Bromoacetyl)-3-phenylisoxazole is known to have certain biological activities and can be used as a building block in medicinal chemistry research. However, it is important to handle this compound with caution, as it can pose health and environmental risks if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 14731-14-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,7,3 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 14731-14:
(7*1)+(6*4)+(5*7)+(4*3)+(3*1)+(2*1)+(1*4)=87
87 % 10 = 7
So 14731-14-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H8BrNO2/c12-7-10(14)11-6-9(13-15-11)8-4-2-1-3-5-8/h1-6H,7H2
14731-14-7Relevant articles and documents
Synthesis and pharmacological characterization of new analogs of broxaterol
De Amici,Conti,Dallanoce,Kassi,Castellano,Stefancich,De Micheli
, p. 69 - 80 (2007/10/03)
A series of isoxazole derivatives structurally related to broxaterol 1 has been prepared and tested for their potency to β1 and β2 adrenergic receptors. At variance with broxaterol, none of the tested compounds displayed agonistic activity. The 3-isopropenyl derivative 5f is the most potent antagonist both in the trachea and atria preparations.
N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents
Chiarino,Grancini,Frigeni,Biasini,Carenzi
, p. 600 - 605 (2007/10/02)
A series of N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives was synthesized and tested on the passive cutaneous anaphylaxis (PCA) model in rats to verify its potential antianaphylactic activity. These compounds were prepared by reaction of an appropri
